The Weight Loss Pill Rivalry Heats Up in Europe Eli Lilly's weight loss pill, Foundayo, has secured its first approval in the UK, a significant milestone for the company.
However, it also highlights Novo Nordisk's dominant position in the European market.
Beneath this straightforward observation lies a complex dynamic: two pharmaceutical giants engaged in an escalating battle for dominance.